According to a new market report published by Lucintel, the future of the coagulation testing market looks promising with opportunities in the activated clotting time (ACT), thrombin time (TT), partial thromboplastin time (PTT), activated partial thromboplastin time (aPTT), and prothrombin time (PT) applications. The global coagulation testing market is expected to grow with a CAGR of 8% from 2020 to 2025. The major drivers for this market are rising prevalence of blood disorders & cardiovascular diseases, increasing geriatric population, and advancement in technologies such as easy-to-use and faster devices with advanced sensors technology.
To download report brochure, please go to https://www.lucintel.com/coagulation-testing-market.aspx and click "download brochure" tab from the menu
Coagulation testing is similar to blood test which measure blood's ability to clot and how long it takes to clot. It helps in accessing risk of excessive bleeding or developing clots in blood vessels. In this market, instruments and consumables are the major products. Lucintel forecasts that consumables will remain the largest segment over the forecast period due to increasing research and development activities related to analyzers and rising technological advancements.
Within this market, hospitals will remain the largest segment by end user over the forecast period due to increasing demand for comprehensive medical care and new innovation in therapeutic techniques.
Asia-Pacific is expected to witness the highest growth over the forecast period due to increasing cases of blood disorders, growing geriatric population, and rising healthcare spending in the region.
Alere, Nihon Kohden, Roche, Sysmex, Thermo Fisher Scientific, Diagnostica Stago, Helena Laboratories, Abbott Laboratories, Medtronic, and Micropoint Biosciences are among the major suppliers in the global coagulation testing market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global coagulation testing market by product, technology, application, end user, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Coagulation Testing Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global coagulation testing market by product, technology, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
Optical Technology
Mechanical Technology
Electrochemical Technology
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Activated Clotting Time
Thrombin Time
Partial Thromboplastin Time
Activated Partial Thromboplastin Time
Prothrombin Time
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Spain
German
France
A more than 150 pages research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.